![PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e476a9c49780bf38ebb73175bec4b850d243f92/2-Figure1-1.png "PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar")
PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar
Targeting the Hedgehog Pathway Holds Promises and Pitfalls
Cureus | Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma
Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe | Cell Death & Disease
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis | Acta Neuropathologica Communications | Full Text
Frequently Asked Questions about Odomzo® (Sonidegib) - CancerConnect
Sonidegib Capsules
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update | Future Oncology
Cells | Free Full-Text | Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer | HTML
Sonidegib: mechanism of action, pharmacology, and clinical utility for | OTT
Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas - ScienceDirect
The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma - ScienceDirect
ODOMZO (sonidegib) for Locally Advanced Basal Cell Carcinoma - Cancer Therapy Advisor
Ignyta's Cancer Drug Inhibitor of Hedgehog Smoothened Pathway Licensed from Lilly | Cancer Biology
Frontiers | Sonidegib for the Treatment of Advanced Basal Cell Carcinoma | Oncology
ODOMZO® (sonidegib) | Resources
Odomzo (sonidegib) for the Treatment of Locally Advanced Basal Cell Carcinoma - Clinical Trials Arena
Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib | PNAS
Sonidegib Phosphate
Sonidegib: mechanism of action, pharmacology, and clinical utility for | OTT
Sonidegib - an overview | ScienceDirect Topics
Sonidegib (Odomzo) for the Systemic Treatment of Adults With Recurrent, Locally Advanced Basal Cell Skin Cancer. - Abstract - Europe PMC
Hedgehog signaling inhibitors in solid and hematological cancers - Cancer Treatment Reviews
Sonidegib | C26H26F3N3O3 - PubChem
